# Androgenic Alopecia TH07 Clinical Trial

> **NCT07435012** · PHASE3 · RECRUITING · sponsor: **Triple Hair Inc** · enrollment: 420 (estimated)

## Conditions studied

- Androgenic Alopecia

## Interventions

- **DRUG:** TH07
- **DRUG:** TH07
- **DRUG:** Minoxidil 5% Topical Solution
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT07435012
- **Lead sponsor:** Triple Hair Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-04
- **Primary completion:** 2027-12
- **Final completion:** 2028-04
- **Target enrollment:** 420 (ESTIMATED)
- **Last updated:** 2026-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07435012

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07435012, "Androgenic Alopecia TH07 Clinical Trial". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07435012. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*